Contemporary roles of registries in clinical cardiology: When do we need randomized trials?

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 12, 2014, Pages 1383-1386

  Ieva, Francesca ^a   Gale, Chris P ^b   Sharples, Linda D ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Clinical cardiology; Clinical practice; Clinical registries; Evidence based medicine; Observational data; Randomized controlled trials; Routinely collected data

Indexed keywords

CARDIOLOGY; CLINICAL PRACTICE; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DISEASE REGISTRY; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; LONG TERM SURVIVAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; TOTAL QUALITY MANAGEMENT; EVIDENCE BASED MEDICINE; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; RESEARCH;

CARDIOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH; RESEARCH DESIGN;

EID: 84912065279     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.982096     Document Type: Review

References (29)

1. Gale CP, Weston C, Denaxas S, et al. NICOR Executive. Engaging with the clinical data transparency initiative: a view from the National Institute for Cardiovascular Outcomes Research (NICOR). Heart 2012;98(14):1040-3
2. Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010;96(20):1617-21
3. NCDR - National Cardiovascular Data Registry: the American College of Cardiology suite of data. Available from: www.ncdr.com/webncdr/home/
4. Designing and mining a multicenter observational clinical registry concerning patients with acute coronary syndromes. new diagnostic, therapeutic and organizational strategies for patients with Acute Coronary Syndromes. eds. Ieva F Grieco N, Paganoni AM, Marzegalli M. Springer; Verlag Italia: 2013. chap 3:47-60
5. Torgerson DJ, Roberts C. Randomisation methods: concealment. BMJ 1999;319:75
6. Ho PM, Peterson PM, Masoudi FA. Evaluating the evidence: is there a rigid hierarchy. Circulation 2008;118:1675-84
7. Olsen R, Bell S, Orr L, et al. External Validity in Policy Evaluations that Choose Sites Purposively. J Policy Anal Manage 2013;32(1):107-21
8. Ezekowitz JA, Hu J, Delgado D, et al. Acute heart failure: perspectives from a randomized trial and a simultaneous registry. Circ Heart Fail 2012;5(6):735-41
9. Stuart E, Cole SR, Bradshaw CP, et al. The use of propensity scores to assess the generalizability of results from randomized trials. JRSS-A 2011;174:369-86
10. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967;21:637-48
11. Alexander PE, Bero L, Montori VM, et al. World Health Organization recommendations are often strong based on low confidence in effect estimates. J Clin Epidemiol 2014;67
12. Venekamp RP, Rovers MM, Hoes AW, et al. Subgroup analysis in randomized controlled trials appeared to be dependent on whether relative or absolute effect measures were used. J Clin Epidemiol 2014;67:410-15
13. Lundh A, Sismondo S, Lexchin J, et al. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2012;12:MR000033
14. Dascanio V, Birks Y, Clark L, et al. Randomized cohort trial was shown to be feasible for evaluating treatments in low back pain. J Clin Epidemiol 2014;67(8):940-6
15. Fröbert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 2013;369(17):1587-97
16. NICE - National Institute for Health and Care Excellence. Available from: www.nice.org.uk/guidance
17. Tannen RL, Weiner MG, Xie D. Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomized controlled trial findings. BMJ 2009;338:b81
18. Weiner MG, Xie D, Tannen RL. Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding. Pharmacoepidemiol Drug Saf 2008;17:661-70
19. Tannen RL, Weiner MG, Xie D. Replicated studies of two randomized trials of angiotensin converting enzyme inhibitors: further empiric validation of the "prior event rate ratio" to adjust for unmeasured confounding by indication. Pharmacoepidemiol Drug Saf 2008;17:671-85
20. Ferreira-González I, Busse JW, Heels-Ansdell D, et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ 2007;334(7597):786
21. Lauer MS, D'Agostino RB. Sr. The randomized registry trial-the next disruptive technology in clinical research? N Engl J Med 2013;369(17):1579-81
22. Ludman PF. British Cardiovascular Intervention Society Registry for audit and quality assessment of percutaneous coronary interventions in the United Kingdom. Heart 2011;97(16):1293-7
23. Kang N, Sobieraj DM. Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism. Thromb Res 2014;133(6):1145-51
24. Felker GM, Ahmad T, Anstrom KJ. Rationale and design of the GUIDE-IT Study: guiding evidence based therapy using biomarker intensified treatment in heart failure. JACC Heart Fail 2014;2(5):457-65
25. Chin CT, Roe MT, Fox KA, et al. TRILOGY ACS Steering Committee. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Am Heart J 2010;160(1):16-22
26. Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv 2014;7(8):898-904
27. Trenk D, Stone GW, Gawaz M, et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (testing platelet reactivity in patients undergoing elective stent placement on clopidogrel to guide alternative therapy with prasugrel) study. J Am Coll Cardiol 2012;59(24):2159-64
28. Relton C, Torgerson D, O'Cathain A, et al. Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ 2010;340:c1066
29. Fröbert O, Lagerqvist B, Gudnason T, et al. Thrombus aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial): a multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish Angiography and Angioplasty Registry (SCAAR) platform: study design and rationale. Am Heart J 2010;160:1042-8